Jpmorgan Chase & CO Novartis Ag Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Novartis Ag stock. As of the latest transaction made, Jpmorgan Chase & CO holds 312,076 shares of NVS stock, worth $30.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
312,076
Previous 317,814 1.81%
Holding current value
$30.6 Million
Previous $33.8 Million 6.09%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$106.13 - $120.89 $608,973 - $693,666
-5,738 Reduced 1.81%
312,076 $35.9 Million
Q3 2024

Nov 08, 2024
SELL
$106.13 - $120.89 $608,973 - $693,666
-5,738 Reduced 1.81%
312,076 $35.9 Million
Q2 2024

Dec 26, 2024
BUY
$92.57 - $107.37 $531,166 - $616,089
5,738 Added 1.84%
317,814 $33.8 Million
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $8.06 Million - $9.34 Million
-87,017 Reduced 21.49%
317,814 $33.8 Million
Q1 2024

Dec 26, 2024
BUY
$95.27 - $108.47 $8.84 Million - $10.1 Million
92,755 Added 29.72%
404,831 $39.2 Million
Q1 2024

May 10, 2024
BUY
$95.27 - $108.47 $5.18 Million - $5.9 Million
54,370 Added 15.51%
404,831 $39.2 Million
Q4 2023

Dec 26, 2024
BUY
$92.27 - $101.54 $3.54 Million - $3.9 Million
38,385 Added 12.3%
350,461 $35.4 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $870,844 - $958,334
-9,438 Reduced 2.62%
350,461 $35.4 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $2.57 Million - $2.85 Million
-27,138 Reduced 7.01%
359,899 $36.7 Million
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $2.22 Million - $2.52 Million
-24,038 Reduced 5.85%
387,037 $39.1 Million
Q1 2023

May 11, 2023
SELL
$80.03 - $92.81 $1.97 Million - $2.29 Million
-24,656 Reduced 5.66%
411,075 $37.8 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $8.39 Million - $10.3 Million
-111,014 Reduced 20.3%
435,731 $39.5 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $8.67 Million - $10.1 Million
-116,250 Reduced 17.53%
546,745 $41.6 Million
Q2 2022

Aug 11, 2022
BUY
$80.52 - $93.75 $35.8 Million - $41.7 Million
444,401 Added 203.3%
662,995 $56 Million
Q1 2022

May 11, 2022
SELL
$80.11 - $90.62 $3.99 Million - $4.51 Million
-49,776 Reduced 18.55%
218,594 $19.2 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $3.04 Million - $3.36 Million
-38,165 Reduced 12.45%
268,370 $23.5 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $25.1 Million - $29.2 Million
306,535 New
306,535 $25.1 Million

Others Institutions Holding NVS

# of Institutions
1,428
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $211B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email